04/09/2024
12:17 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
03/19/2024
5:43 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:44 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:44 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:45 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:16 AM | Revance Therapeutics (Subject)
Sjuts Dustin S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
5:10 AM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/18/2024
5:13 AM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:33 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:44 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:39 AM | Revance Therapeutics (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Hollander David (Reporting)
Revance Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/29/2024
3:36 PM | Jordan Erica (Reporting)
Revance Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/28/2024
3:07 PM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:55 PM | Palo Alto Investors LP (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
2:45 PM | Antara Capital LP (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
8:39 AM | Polar Capital Holdings Plc (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
5:21 PM | Capital World Investors (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | GIC Private Ltd (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
02/06/2024
12:58 PM | FRANKLIN RESOURCES INC (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G | |
02/02/2024
3:46 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:48 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:45 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
10:10 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
10:11 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Revance Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
7:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
3:50 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:32 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:22 PM | Revance Therapeutics (Filer)
| Form S-3ASR | |
09/19/2023
8:01 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
4:37 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
3:21 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
4:43 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/01/2023
8:12 AM | Revance Therapeutics (Subject)
Teoxane SA (Filed by)
| Form SC 13D | |
08/14/2023
7:02 AM | Revance Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
3:40 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
8:11 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
8:11 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
3 Sub-$10 Stocks to Buy for 2024 (Ad) Often, investors will overlook stocks just because they're cheap.
It's a common thought that a cheap price tag means that something must be wrong with the company.
But this couldn't be further from the case in many instances. Get your FREE look at these THREE companies right here. |
07/05/2023
8:11 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
1:29 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
1:33 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/15/2023
7:30 PM | Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
7:09 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2023
7:09 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:07 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
7:08 PM | Revance Therapeutics (Subject)
Sjuts Dustin S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
5:06 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
4:34 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
4:14 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2023
7:29 PM | Revance Therapeutics (Issuer)
Sjuts Dustin S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:29 PM | Foley Mark J (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:29 PM | Revance Therapeutics (Issuer)
Schilke Tobin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
7:29 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
7:25 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:18 PM | Moxie Dwight (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:16 PM | Foley Mark J (Reporting)
Revance Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:17 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/12/2023
3:18 PM | Revance Therapeutics (Subject)
Sjuts Dustin S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2023
3:34 PM | Revance Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2023
4:13 PM | Beraud Jill (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Coric Vlad (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Revance Therapeutics (Issuer)
Russell Angus C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Kolaja Carey OConnor (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:14 PM | Nolet Chris (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:15 PM | Revance Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2023
4:15 PM | Gangolli Julian S (Reporting)
Revance Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2023
4:41 PM | Revance Therapeutics (Subject)
Schilke Tobin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
